InvestorsHub Logo
icon url

lizzy241

08/15/20 11:20 AM

#291427 RE: ilovetech #291424

ILT,
Because Afimmune is competition it doesn't mean that Amarin couldn't swoop them up and tuck them into a subsidiary. It happened in the taser patent deal that Du referred to in the May article written in the Nevada law review mag when she mentioned that she was being tutored on technical issues such as how taser work and the benefits of fish oil. It happened that Taser Intl was bought out by Axon because they lost the patent lawsuit and Axon said the hell with them and just went ahead and bought Taser Intl.
Same could happen with Amarin and Afimmune. The synergies are there and Afimmune has only $400,000 in revs. losing a bunch of money so why not!